LIST OF PUBLICATIONS IN INTERNATIONAL PEER-REVIEWED JOURNALS

1. Glomerular Diseases Across Lifespan: Key Differences in Diagnostic and Therapeutic Approaches.

Windpessl, M, Odler, B, Bajema, IM, Geetha, D, Säemann, M, Lee, JM, Vaglio, A, & Kronbichler, A. 

Seminars in nephrology, 2023 151435. https://doi.org/10.1016/j.semnephrol.2023.151435. Advance online publication. 

2. Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying.

Gisslander, K., Rutherford, M., Aslett, L., Basu, N., Dradin, F., Hederman, L., Hruskova, Z., Kardaoui, H., Lamprecht, P., Lichołai, S., Musial, J., O'Sullivan, D., Puechal, X., Scott, J., Segelmark, M., Straka, R., Terrier, B., Tesar, V., Tesi, M., Vaglio, A., … FAIRVASC consortium.

Annals of the rheumatic diseases, 2023. https://doi.org/10.1136/ard-2023-224571. Advance online publication.

3. Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group.

Caminati, M., Fassio, A., Alberici, F., Baldini, C., Bello, F., Cameli, P., Conticini, E., Cottin, V., Crimi, C., Dagna, L., Delvino, P., Deroux, A., Duran, E., Espigol-Frigole, G., Karadag, O., Maule, M., Moiseev, S., Monti, S., Moroni, L., Padoan, R., …, Vaglio A., Emmi, G. 

Allergy, 2023. https://doi.org/10.1111/all.15934. Advance online publication. 

4. Smoking in antineutrophil cytoplasmic antibody-associated vasculitis: from disease susceptibility to long-term prognosis.

Lugli, G., Peyronel, F., & Vaglio, A.

Polish archives of internal medicine, 2023 133(10), 16593. https://doi.org/10.20452/pamw.16593

5. Peyronel, F., Haroche, J., MD, PhD, Campochiaro, C., Pegoraro, F., Amoura, Z., Tomelleri, A., Mazzariol, M., Papo, M., Cavalli, G., Benigno, G. D., Fenaroli, P., Grigoratos, C., Mengoli, M. C., Bonometti, A., Berti, E., Savino, G., Cives, M., Neri, I., Pacinella, G., Tuttolomondo, A., …, Vaglio A., Cohen Aubart, F. 

Epidemiology and geographic clustering of Erdheim-Chester disease in italy and France. 

Blood, 2023 blood.2023021670. https://doi.org/10.1182/blood.2023021670. Advance online publication.

6. Cluster Analysis To Explore Clinical Subphenotypes Of Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss). 

Rubenstein E, Maldini C, Vaglio A, Bello F, Bremer JP, Moosig F, Bottero P, Pesci A, Sinico RA, Grosskreutz J, Feder C, Saadoun D, Trivioli G, Maritati F, Rewerska B, Szczeklik W, Fraticelli P, Guida G, Gregorini G, Moroncini G, Hellmich B, Zwerina J, Resche-Rigon M, Emmi G, Neumann T, Mahr A. 

J Rheumatol. 2023 Sep 1:jrheum.2022-0325. doi: 10.3899/jrheum.2022-0325. Epub ahead of print. PMID: 37657795.

7. Overcoming challenges in rare disease registry integration using the semantic web - a clinical research perspective. 

Gisslander K, Mohammad AJ, Vaglio A, Little MA. 

Orphanet J Rare Dis. 2023 Aug 29;18(1):253. doi: 10.1186/s13023-023-02841-z. PMID: 37644439; PMCID: PMC10466902.

8. Genome-wide association study identifies the first germline genetic variant associated with Erdheim Chester disease. Martínez-López J, Márquez A, Pegoraro F, Ortiz-Fernández L, Acosta-Herrera M, Kerick M, Gelain E, Diamond EL, Durham BH, Abdel-Wahab O, Go RS, Koster MJ, Dagna L, Campochiaro C, Collin M, Milne P, Estrada-Veras JI, O'Brien K, Papo M, Cohen-Aubar F, Amoura Z, Haroche J, Martín J, Vaglio A. 

Arthritis Rheumatol. 2023 Aug 10. doi: 10.1002/art.42673. Epub ahead of print. PMID: 37561109.

9. Childhood-onset Erdheim-Chester Disease in the molecular era: clinical phenotype and long-term outcome of 21 patients. 

Pegoraro F, Mazzariol M, Trambusti I, Bakhshi S, Mallick S, Dunkel IJ, van den Bos C, Tezol O, Shan S, Ocak S, Giordano F, De Fusco C, Gaspari S, Buccoliero A, Coniglio ML, Buti E, Romagnani P, Picarsic J, Donadieu J, Diamond EL, Emile JF, Sieni E, Haroche J, Vaglio A. 

1.  2023 Jul 25:blood.2023020569. doi: 10.1182/blood.2023020569. Epub ahead of print. PMID: 37490651.

1. CKD therapy to improve outcomes of immune-mediated glomerular diseases. 

Anders HJ, Fernandez-Juarez GM, Vaglio A, Romagnani P, Floege J. 

Nephrol Dial Transplant. 2023 May 22:gfad069. doi: 10.1093/ndt/gfad069. Epub ahead of print. PMID: 37218706.

1. Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis.

Emmi G, Bettiol A, Gelain E, Bajema IM, Berti A, Burns S, Cid MC, Cohen Tervaert JW, Cottin V, Durante E, Holle JU, Mahr AD, Del Pero MM, Marvisi C, Mills J, Moiseev S, Moosig F, Mukhtyar C, Neumann T, Olivotto I, Salvarani C, Seeliger B, Sinico RA, Taillé C, Terrier B, Venhoff N, Bertsias G, Guillevin L, Jayne DRW, Vaglio A. 

Nat Rev Rheumatol. 2023 Jun;19(6):378-393. doi: 10.1038/s41584-023-00958-w. Epub 2023 May 9. PMID: 37161084.

2.  IgG4-related disease: advances in pathophysiology and treatment. Peyronel F, Fenaroli P, Maritati F, Schleinitz N, Vaglio A.

Expert Rev Clin Immunol. 2023 Apr 6:1-11. 

3. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. 

Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, Holle JU, Hollinger N, Karadag O, Kronbichler A, Little MA, Luqmani RA, Mahr A, Merkel PA, Mohammad AJ, Monti S, Mukhtyar CB, Musial J, Price-Kuehne F, Segelmark M, Teng YKO, Terrier B, Tomasson G, Vaglio A, Vassilopoulos D, Verhoeven P, Jayne D. 

Ann Rheum Dis. 2023 Mar 16:ard-2022-223764. doi: 10.1136/ard-2022-223764. Epub ahead of print. PMID: 36927642.

4.  Unmet needs in ANCA-associated vasculitis: Physicians' and patients' perspectives. 

       Quartuccio L, Treppo E, Urso L, Del Frate G, Mescia F, Alberici F, Vaglio A, Emmi G. 

Front Immunol. 2023 Feb 23;14:1112899. 

5.  The new look of classification criteria for systemic vasculitis 

Emmi G, Vaglio A. 

Nat Rev Rheumatol.  2023 Apr;19(4):198-199. doi: 10.1038/s41584-023-00933-5. PMID: 36829067.

6.  Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing. 

Ortiz-Fernández L, Carmona EG, Kerick M, Lyons P, Carmona FD, López Mejías R, Khor CC, Grayson PC, Tombetti E, Jiang L, Direskeneli H, Saruhan-Direskeneli G, Callejas-Rubio JL, Vaglio A, Salvarani C, Hernández-Rodríguez J, Cid MC, Morgan AW, Merkel PA, Burgner D, Smith KG, Gonzalez-Gay MA, Sawalha AH, Martin J, Marquez A. 

        Ann Rheum Dis. 2023 Jun;82(6):837-847.

7.  A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases. 

Becherucci F, Landini S, Palazzo V, Cirillo L, Raglianti V, Lugli G, Tiberi L, Dirupo E, Bellelli S, Mazzierli T, Lomi J, Ravaglia F, Sansavini G, Allinovi M, Giannese D, Somma C, Spatoliatore G, Vergani D, Artuso R, Rosati A, Cirami C, Dattolo PC, Campolo G, De Chiara L, Papi L, Vaglio A, Lazzeri E, Anders HJ, Mazzinghi B, Romagnani P. 

        J Am Soc Nephrol.  2023 Apr 1;34(4):706-720.

8.  Editorial: The kidney in auto-immune and auto-inflammatory processes: Definitions, mechanisms, and biomarkers. 

         Vaglio A, Gattorno M, McAdoo S, Obici LP, Ghiggeri GM. 

         Front Med (Lausanne). 2023 Jan 10;9:1129021. 

9.   Chronic periaortitis: A clinical approach. 

         Gianfreda D, Superchi E, Peyronel F, Mazzariol M, Vaglio A.

         Rev Med Interne. 2023 Feb;44(2):79-84. 

1.  Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis.

Chazal T, Pegoraro F, Manari G, Bettiol A, Maniscalco V, Gelain E, Charlotte F, Mazor RD, Renard-Penna R, Amoura Z, Cohen-Aubart F, Haroche J, Izzedine H, Vaglio A.

Kidney Int. 2023;103(1):177-186. 

1.  The complement system in antineutrophil cytoplasmic antibody-associated vasculitis: pathogenic player and therapeutic target. 

         Mazzariol M, Manenti L, Vaglio A. 

         Curr Opin Rheumatol. 2023;35(1):31-36.

2. Kidney involvement in Rosai-Dorfman disease.

Mazzariol M, Peyronel F, Fagni F, Minervini A, Santi R, Agostini S, Vaglio A. 

Kidney Int. 2023;103(1):231-232. 

3.  Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study. 

Podestà MA, Mescia F, Ricchiuto A, Smith R, Tedesco M, Cassia MA, Holle J, Sinico RA, Bruchfeld A, Gunnarsson I, Ohlsson S, Baslund B, Hruskova Z, Tesar V, Sabiu G, Gallieni M, Cid MC, Vaglio A, Harper L, Cozzolino M, Scolari F, Jayne D, Alberici F. 

        Rheumatology (Oxford). 2023 Aug 1;62(8):2850-2854.

4.  Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis.

Rossi GM, Maggiore U, Peyronel F, Fenaroli P, Delsante M, Benigno GD, Gianfreda D, Urban ML, Manna Z, Arend LJ, Bagnasco S, Vaglio A, Fiaccadori E, Rosenberg AZ, Hasni S, Manenti L. 

Kidney Int Rep. 2022;7(12):2647-2656. 

5. Registries of rare diseases: current knowledge and future perspectives. 

Gelain E, Tesi M, Mazzariol M, Vaglio A.

Intern Emerg Med. Intern Emerg Med. 2023 Jan;18(1):19-21

6.  Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunities.

Berti A, Atzeni F, Dagna L, Del Giacco S, Emmi G, Salvarani C, Vaglio A. 

Ann Rheum Dis. 2022:ard-2022-223044. 

7.  2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis.

Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Watts RA, Merkel PA, Luqmani RA; DCVAS Study Group. 

Ann Rheum Dis. 2022;81(12):1647-1653. (Dr Vaglio is a member of the DCVAS study group)

8.  2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. 

Grayson PC, Ponte C, Suppiah R, Robson JC, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Danda D, Luqmani RA, Watts RA, Merkel PA; DCVAS Study Group. 

Ann Rheum Dis. 2022;81(12):1654-1660. (Dr Vaglio is a member of the DCVAS study group)

9.  2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis.

Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Watts RA, Merkel PA, Luqmani RA; DCVAS Study Group. 

Arthritis Rheumatol. 2022. (Dr Vaglio is a member of the DCVAS study group)

1.  2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis.

Grayson PC, Ponte C, Suppiah R, Robson JC, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Danda D, Luqmani RA, Watts RA, Merkel PA; DCVAS Study Group. 

Arthritis Rheumatol. 2022. (Dr Vaglio is a member of the DCVAS study group)

1.  At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement.

Bond M, Fagni F, Moretti M, Bello F, Egan A, Vaglio A, Emmi G, Dejaco C. 

Curr Rheumatol Rep. 2022;24(11):337-351. 

2.  Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management. 

Trivioli G, Marquez A, Martorana D, Tesi M, Kronbichler A, Lyons PA, Vaglio A. 

Nat Rev Rheumatol. 2022;18(10):559-574. 

3.  Evidence for charge-based mimicry in anti dsDNA antibody generation.

Bruschi M, Angeletti A, Kajana X, Moroni G, Sinico RA, Fredi M, Vaglio A, Cavagna L, Pratesi F, Migliorini P, Locatelli F, Pazzola G, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Esposito P, Negrini S, Bui F, Trezzi B, Emmi G, Cavazzana I, Binda V, Fenaroli P, Pisani I, Montecucco C, Santoro D, Scolari F, Volpi S, Mosca M, Tincani A, Candiano G, Verrina E, Franceschini F, Ravelli A, Prunotto M, Meroni PL, Ghiggeri GM. 

J Autoimmun. 2022;132:102900. 

4.  The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult. 

Tedesco M, Mescia F, Pisani I, Allinovi M, Casazza G, Del Vecchio L, Santostefano M, Cirillo L, Ferrario F, Esposito C, Esposito P, Santoro D, Lazzarin R, Rossi GM, Fiaccadori E, Ferrantelli A, Sinico RA, Cozzolino M, Gallieni M; Italian Society of Nephrology Immunopathology Working Group, Cirami L, Scolari F, Vaglio A, Alberici F. Kidney Int Rep. 2022;7(8):1878-1886. 

5.  The Sound of Interconnectivity; The European Vasculitis Society 2022 Report. 

Egan AC, Kronbichler A, Neumann I, Bettiol A, Carlson N, Cid MC, Emmi G, Gopaluni S, Harper L, Hauser T, Little MA, Luqmani RA, Mahr A, McClure M, Mohammad AJ, Nelveg-Kristensen KE, Ohlsson S, Peh CA, Rutherford M, Alamo BS, Scott J, Segelmark M, Smith RM, Szpirt WM, Tomasson G, Trivioli G, Vaglio A, Walsh M, Wester Trejo M, Westman K, Bajema IM, Jayne DRW. 

Kidney Int Rep. 2022;7(8):1745-1757. 

6.  Evidence of subclinical atherosclerosis in Eosinophilic Granulomatosis with Polyangiitis (EGPA).

Bello F, Bettiol A, Silvestri E, Mattioli I, Urban ML, Palermo A, Mazzetti M, Malandrino D, Calcaterra I, Vaglio A, Di Minno MND, Emmi G, Prisco D. 

Rheumatology (Oxford). 2022:keac427. 

7.  Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study. 

Bettiol A, Urban ML, Bello F, Fiori D, Mattioli I, Lopalco G, Iannone F, Egan A, Dagna L, Caminati M, Negrini S, Bargagli E, Folci M, Franceschini F, Padoan R, Flossmann O, Solans R, Schroeder J, André M, Moi L, Parronchi P, Roccatello D, Sciascia S, Jayne D, Prisco D, Vaglio A, Emmi G; European EGPA Study Group. 

Ann Rheum Dis. 2022;81(12):1769-1772. 

8.  A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon.

Trivioli G, Gelain E, Angelotti ML, Ravaglia F, Allinovi M, Lodi L, Caroti L, Buccoliero A, Emmi G, Gattorno M, Romagnani P, Volpi S, Vaglio A. 

Am J Kidney Dis. 2022;80(5):677-682. 

9.  Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA). 

Niccolai E, Bettiol A, Baldi S, Silvestri E, Di Gloria L, Bello F, Nannini G, Ricci F, Nicastro M, Ramazzotti M, Vaglio A, Bartolucci G, Emmi G, Amedei A, Prisco D. 

1.  2022;10(6):1227. 

1.  Jagged Ends on Multinucleosomal Cell-Free DNA Serve as a Biomarker for Nuclease Activity and Systemic Lupus Erythematosus. 

Ding SC, Chan RWY, Peng W, Huang L, Zhou Z, Hu X, Volpi S, Hiraki LT, Vaglio A, Fenaroli P, Bocca P, Tam LS, Wong PCH, Tam LHP, Jiang P, Chiu RWK, Chan KCA, Lo YMD. 

Clin Chem. 2022:hvac050.

1.  Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis. 

Gatto M, Radice F, Saccon F, Calatroni M, Frontini G, Trezzi B, Zen M, Ghirardello A, Tamborini F, Binda V, L'Imperio V, Doria A, Vaglio A, Sinico RA, Moroni G, Iaccarino L.

Lupus Sci Med. 2022;9(1):e000689

2.  Effects of nucleases on cell-free extrachromosomal circular DNA. 

Sin ST, Deng J, Ji L, Yukawa M, Chan RW, Volpi S, Vaglio A, Fenaroli P, Bocca P, Cheng SH, Wong DK, Lui KO, Jiang P, Chan KCA, Chiu RW, Lo YMD.

JCI Insight. 2022;7(8):e156070.

3.  Type I interferon-related kidney disorders. 

Lodi L, Mastrolia MV, Bello F, Rossi GM, Angelotti ML, Crow YJ, Romagnani P, Vaglio A.

Kidney Int. 2022;101(6):1142-1159

4.  2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis. 

Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, Khalid S, Hutchings A, Luqmani RA, Watts RA, Merkel PA; DCVAS Study Group. 

Ann Rheum Dis. 2022;81(3):309-314 (Dr Vaglio is a member of the DCVAS study group)

5.  2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. 

Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, Judge A, Khalid S, Hutchings A, Watts RA, Merkel PA, Luqmani RA; DCVAS Investigators. (Dr Vaglio is listed among the DCVAS investigators)

Ann Rheum Dis. 2022;81(3):315-320. 

6.  2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. 

Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, Judge A, Hutchings A, Merkel PA, Luqmani RA, Watts RA; DCVAS INVESTIGATORS. 

Ann Rheum Dis. 2022;81(3):321-326. (Dr Vaglio is listed among the DCVAS investigators)

7.  2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis. 

Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, Judge A, Hutchings A, Merkel PA, Luqmani RA, Watts RA; DCVAS Study Group. 

Arthritis Rheumatol. 2022;74(3):400-406. (Dr Vaglio is a member of the DCVAS study group)

8.  2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. 

Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, Khalid S, Hutchings A, Luqmani RA, Watts RA, Merkel PA; DCVAS Study Group. 

Arthritis Rheumatol. 2022;74(3):386-392. (Dr Vaglio is a member of the DCVAS study group)

9.  2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis. 

Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, Judge A, Khalid S, Hutchings A, Watts RA, Merkel PA, Luqmani RA; DCVAS Study Group. 

Arthritis Rheumatol. 2022;74(3):393-399. (Dr Vaglio is a member of the DCVAS study group)

1.  Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: A systematic review and meta-analysis. 

Berti A, Alsawas M, Jawaid T, Prokop LJ, Lee JM, Jeong GH, Quintana LF, Moiseev S, Vaglio A, Tesar V, Geetha D, Shin JI, Kronbichler A. 

Nephrol Dial Transplant. 2021:gfab357. 

1.  Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis.

Allinovi M, Trivioli G, Lugli G, Villanti M, Gianassi I, Antognoli G, Romagnani P, Vaglio A, Caroti L, Cirami CL. Nephrol Dial Transplant. 2022;37(4):789-791

2.  Neutrophil Extracellular Traps-DNase Balance and Autoimmunity 

Angeletti A, Volpi S, Bruschi M, Lugani F, Vaglio A, Prunotto M, Gattorno M, Schena F, Verrina E, Ravelli A, Ghiggeri GM. 

Cells 2021; 10(10): 2667

3.  IgG4-related disease and Rosai-Dorfman-Destombes disease - Authors' reply  

Emile JF, Vaglio A, Cohen-Aubart F, Haroche J. 

Lancet 2021; 398(10307): 1214-1215

4.  The European Vasculitis Society 2016 Meeting Report. 

Bajema IM, Bruijn JA, Casian A, Cid MC, Csernok E, van Daalen E, Harper L, Hauser T, Little MA, Luqmani RA, Mahr A, Ponte C, Salama A, Segelmark M, Suzuki K, Sznajd J, Teng YKO, Vaglio A, Westman K, Jayne D. 

Kidney Int Rep. 2017;2(6):1018-1031

5.  Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: A systematic review and meta-analysis  

Berti A, Alsawas M, Jawaid T, Prokop LJ, Lee JM, Jeong GH, Quintana LF, Moiseev S, Vaglio A, Tesar V, Geetha D, Shin JI, Kronbichler A

Nephrol Dial Transplant. 2022;37(11):2190-2200

6.  Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis 

Allinovi M, Trivioli G, Lugli G, Villanti M, Gianassi I, Antognoli G, Romagnani P, Vaglio A, Caroti L, Cirami CL. 

Nephrol Dial Transplant. 2022; 37(4): 789-791

7.  Second wave antibodies in autoimmune renal diseases:he case of lupus nephritis 

Angeletti A, Bruschi M, Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, Cavagna L, Petretto A, Pratesi F, Migliorini P, Locatelli F, Pazzola G, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Esposito P, Murdaca G, Negrini S, Cipriani L, Trezzi B, Emmi G, Cavazzana I, Binda V, D’Alessandro M, Fenaroli P, Pisani I, Garibotto G, Montecucco CM, Santoro D, Scolari F, Volpi S, Mosca M, Tincani A, Candiano G, Prunotto M, Verrina E, Ravelli A, Ghiggeri GM.

J Am Soc Nephrol 2021; 32(12): 3020-3

8.  Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 

Bettiol A, Urban ML, Dagna L, Cottin V, Franceschini F, Del Giacco S, Schiavon F, Neumann T, Lopalco G, Novikov P, Baldini C, Lombardi C, Berti A, Alberici F, Folci M, Negrini S, Sinico RA, Quartuccio L, Lunardi C, Parronchi P, Moosig F, Espígol-Frigolé G, Schroeder J, Kernder AL, Monti S, Silvagni E, Crimi C, Cinetto F, Fraticelli P, Roccatello D, Vacca A, Mohammad AJ, Hellmich B, Samson M, Bargagli E, Cohen Tervaert JW, Ribi C, Fiori D, Bello F, Fagni F, Moroni L, Ramirez GA, Nasser M, Marvisi C, Toniati P, Firinu D, Padoan R, Egan A, Seeliger B, Iannone F, Salvarani C, Jayne D, Prisco D*, Vaglio A*, Emmi G*; European EGPA Study Group.

Arthritis Rheumatol. 2022; 74(2): 295-306

9.  Monitoring  immune responses in renal autoimmune disease 

Teng YKO, Pusey CD, Vaglio A, Mok CC, van Kooten C.

         Front Immunol 2021; 12: 722791

1.  Prognostic factors and long-term outcome with ANCA-associated kidney vasculitis in childhood 

Calatroni M, Consonni F, Allinovi M, Bettiol A, Jawa N, Fiasella S, Curi D, Abu Rumeileh S, Tomei L, Fortunato L,  Gelain E, Gianfreda E, Oliva E, Jeannin G, Salviani C, Emmi G, Bodria M, Sinico RA, Moroni G, Ramirez GA, Bozzolo E, Tombetti E, Monti S, Bracaglia C, Marucci G, Pastore S, Esposito P, Catanoso MG, Crapella B, Montini G, Roperto R, Materassi M, Rossi GM, Badalamenti S, Yeung RSM, Romagnani P, Ghiggeri GM, Noone D, Vaglio A.

        Clin J Am Soc Nephrol 2021;16(7):1043-1051

1.  Microarray evaluation of allergen-specific IgE in eosinophilic granulomatosis with polyangiitis 

Bello F, Maritati F, Radice A, Sinico RA, Emmi G, Vaglio A. 

         Ann Rheum Dis 2021; 80(9): 1247-1248

2.  Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 

Bettiol A, Sinico RA, Schiavon F, Monti S, Bozzolo EP, Franceschini F, Govoni M, Lunardi C, Guida G, Lopalco G, Paolazzi G, Vacca A, Gregorini G, Leccese P, Piga M, Conti F, Fraticelli P, Quartuccio L, Alberici F, Salvarani C, Bettio S, Negrini S, Selmi C, Sciascia S, Moroni G, Colla L, Manno C, Urban ML, Vannacci A, Pozzi MR, Fabbrini P, Polti S, Felicetti M, Marchi MR, Padoan R, Delvino P, Caporali R, Montecucco C, Dagna L, Cariddi A, Toniati P, Tamanini S, Furini F, Bortoluzzi A, Tinazzi E, Delfino L, Badiu I, Rolla G, Venerito V, Iannone F, Berti A, Bortolotti R, Racanelli V, Jeannin G, Padula A, Cauli A, Priori R, Gabrielli A, Bond M, Tedesco M, Pazzola G, Tomietto P, Pellecchio M, Marvisi C, Maritati F, Palmisano A, Dejaco C, Willeit J, Kiechl S, Olivotto I, Willeit P, Prisco D, Vaglio A*, Emmi G*; Italian EGPA Consortium. 

        Eur Respir J 2021; 57(5): 2004158

3.  Neutrophil Extracellular Traps in the Autoimmunity Context 

Bruschi M, Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, Cavagna L, Petretto A, Pratesi F, Migliorini P, Manfredi A, Ramirez GA, Esposito P, Negrini S, Trezzi B, Emmi G, Santoro D, Scolari F, Volpi S, Mosca M, Tincani A, Candiano G, Prunotto M, Verrina E, Angeletti A, Ravelli A, Ghiggeri GM. 

         Front Med (Lausanne) 2021; 8: 614829

4.  Occupational exposures and smoking in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 

Maritati F, Peyronel F, Fenaroli P, Pegoraro F, Lastrucci V, Benigno GD, Palmisano A, Rossi GM, Urban ML, Alberici F, Fraticelli P, Emmi G, Corradi M, Vaglio A.

Arthritis Rheumatol 2021; 73(9): 1694-1702

5.  Collapsing glomerulopathy as a ocmplication of type I Interferon-mediated glomerulopathy in a patient with RNASEH2B-related Aicardi-Goutières Syndrome 

Fenaroli P, Rossi GM, Angelotti ML, Antonelli G, Volpi S, Grossi A, Delsante M, Lodi L, Landini L,  Romagnani. P, Vaglio A.

        Am J Kidney Dis 2021; 78(5): 750-754

6.  IgG4-related disease: not just a matter of IgG4 

Trivioli G, Bond M, Emmi G, Vaglio A.

         Rheumatology 2021; 60(Suppl 3): iii35-iii38

7.  Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 

Zampieri M, Emmi G, Beltrami M, Fumagalli C, Urban ML, Dei L, Marchi A, Berteotti M, Tomberli A, Baldini K, Bettiol A, Pradella S, Silvestri E, Marchionni N, Vaglio A, Olivotto I, Prisco D.

        Eur J Intern Med 2021; 85: 68-79

8.  ANCA testing: where are we now? 

Bond M, Fagni F, Vaglio A.

        Intern Emerg Med 2021; 16(2): 269-271

9.  Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes. 

Monti S, Craven A, Klersy C, Montecucco C, Caporali R, Watts R, Merkel PA, Luqmani R; DCVAS Collaborators. Rheumatology (Oxford). 2021 Feb 1;60(2):617-628. (Dr Vaglio is a member of the DCVAS study group)

1.  Into clinical practice: diagnosis and therapy of retroperitoneal fibrosis 

Fenaroli P, Maritati F, Vaglio A.

        Curr Rheumatol Rep 2021; 23(3): 18

1.  Significance of PR3-ANCA Positivity in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) 

Papo M, Sinico RA, Teixeira V, Venhoff N, Urban ML, Iudici M, Mahrhold J, Locatelli F, Cassone G, Schiavon F, Seeliger B, Neumann T, Kroegel C, Groh M, Marvisi C, Samson M, Barba T, Jayne D, Troilo A, Thiel J, Hellmich B, Monti S, Montecucco C, Salvarani C, Kahn JE, Bonnotte B, Durel CA, Puéchal X, Mouthon L, Guillevin L, Emmi G, Vaglio A, Terrier B. 

        Rheumatology 2021; 60(9): 4355-4360

2.  Multi-autoantibody Signature and Clinical Outcome in Membranous Nephropathy 

Ghiggeri GM, Seitz-Polski B, Justino J, Zaghrini C, Payré C, Brglez V, Dolla G, Sinico A, Scolari F, Vaglio A, Prunotto M, Candiano G, Radice A, Bruschi M, Lambeau G; Italian Study Group for Membranous Nephropathy. Clin J Am Soc Nephrol 2020; 15(12): 1762-1776

3.  Serum IgG2 antibody multi-composition in Systemic Lupus Erythematosus and in Lupus nephritis (Part 2).  Prospective study 

Bruschi M, Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, Cavagna L, Petretto A, Pratesi F, Migliorini P, Locatelli F, Pazzola G, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Esposito P, Murdaca G, Negrini S, Cipriani L, Trezzi B, Emmi G, Cavazzana I, Binda V, d'Alessandro M, Fenaroli P, Pisani I, Garibotto G, Montecucco C, Santoro D, Scolari F, Volpi S, Mosca M, Tincani A, Candiano G, Prunotto M, Verrina E, Angeletti A, Ravelli A, Ghiggeri GM. 

        Rheumatology 2021; 60(7): 3388-3397

4. Serum IgG2 antibody  multi-composition in Systemic Lupus Erythematosus and in Lupus nephritis (Part 1). Cross-sectional analysis 

Bruschi M, Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, Cavagna L, Petretto A, Pratesi F, Migliorini P, Locatelli F, Pazzola G, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Esposito P, Murdaca G, Negrini S, Cipriani L, Trezzi B, Emmi G, Cavazzana I, Binda V, Fenaroli P, Pisani I, Garibotto G, Montecucco C, Santoro D, Scolari F, Mosca M, Tincani A, Candiano G, Prunotto M, Volpi S, Verrina E, Angeletti A, Ravelli A, Ghiggeri GM. 

Rheumatology 2021; 60(7): 3176-3188

5.  Ultrasound to address medullary sponge kidney: a retrospective study 

Pisani I, Giacosa R, Giuliotti S, Moretto D, Regolisti G, Cantarelli C, Vaglio A, Fiaccadori E, Manenti L.

         BMC Nephrol 2020; 21(1): 430

6.  Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis with Polyangiitis: data from a European Collaborative Study

Canzian A, Venhoff N, Urban ML, Sartorelli S, Ruppert AM, Groh M, Girszyn N, Taillé C, Maurier F, Cottin V, de Moreuil C, Germain V, Samson M, Jachiet M, Denis L, Rieu V, Smets P, Pugnet G, Deroux A, Durel CA, Aouba A, Cathébras P, Deligny C, Faguer S, Gil H, Godeau B, Lifermann F, Phin-Huynh S, Ruivard M, Bonniaud P, Puéchal X, Kahn JE, Thiel J, Dagna L, Guillevin L, Vaglio A, Emmi G, Terrier B; French Vasculitis Study Group (FVSG), the European EGPA Study Group.

        Arthritis Rheumatol 2021; 73(3): 498-503

7.  The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy 

Trivioli G, Vaglio A.

         Clin Exp Immunol 2020; 202(3): 403-406

8.  IgG4-related disease: a contemporary review 

Karadeniz H, Vaglio A.

        Turk J Med Sci 2020; 50(SI-2): 1616-1631

9.  Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis 

Smith RM, Smith RM, Jones RB, Specks U, Bond S, Nodale M, Aljayyousi R, Andrews J, Bruchfeld A, Camilleri B, Carette S, Cheung CK, Derebail V, Doulton T, Forbess L, Fujimoto S, Furuta S, Gewurz-Singer O, Harper L, Ito-Ihara T, Khalidi N, Klocke R, Koening C, Komagata Y, Langford C, Lanyon P, Luqmani RA, Makino H, McAlear C, Monach P, Moreland LW, Mynard K, Nachman P, Pagnoux C, Pearce F, Peh CA, Pusey C, Ranganathan D, Rhee RL, Spiera R, Sreih AG, Tesar V, Walters G, Weisman MH, Wroe C, Merkel P, Jayne D; RITAZAREM coinvestigators (Dr Vaglio included as collaborator)

        Ann Rheum Dis 2020; 79(9): 1243-1249

1.  Erdheim-Chester disease: a rapidly evolving disease model 

Pegoraro F, Papo M, Maniscalco V, Charlotte F, Haroche J, Vaglio A.

        Leukemia 2020; 34(11): 2840-2857

1.  International consensus on ANCA testing in eosinophilic granulomatosis with polyangiitis 

Moiseev S, Bossuyt X, Arimura Y, Blockmans D, Csernok E, Damoiseaux J, Emmi G, Flores-Suárez LF, Hellmich B, Jayne D, Jennette JC, Little MA, Mohammad AJ, Moosig F, Novikov P, Pagnoux C, Radice A, Sada K, Segelmark M, Shoenfeld Y, Sinico RA, Specks U, Terrier B, Tzioufas AG, Vaglio A, Zhao M-H, Cohen Tervaert JW; on behalf of the European EGPA Study Group

Am J Resp Crit Care Med 2020; 202(10): 1360-1372

2.  Slowly progressive ANCA-associated renal vasculitis. Clinico-pathological characterisation and outcome 

Trivioli G, Gopaluni S, Urban ML, Gianfreda D, Cassia MA, Vercelloni PG, Calatroni M, Bettiol A, Esposito P, Murtas C, Alberici F, Maritati F, Manenti L, Palmisano A, Emmi G, Romagnani P, Moroni G, Gregorini G, Sinico RA, Jayne D, Vaglio A.

        Clin Kidney J 2020;14(1): 332-340

3.  Lack of EULAR/ERA-EDTA response at one year predicts poor long-term renal outcome in patients with lupus nephritis 

Moroni G, Gatto M, Tamborini F, Quaglini S, Radice F, Saccon F, Frontini G, Alberici F, Sacchi L, Binda V, Trezzi  B, Vaglio A, Messa O, Sinico RA, Doria A.

        Ann Rheum Dis 2020; 79(8): 1077-1083

4.  SARS-CoV-2 infection among patients with systemic autoimmune diseases 

Emmi G, Bettiol A, Mattioli I, Silvestri E, Di Scala G, Urban ML, Vaglio A, Prisco D. 

Autoimmun Rev 2020; 19(7):102575

5.  New therapeutics for ANCA-associated vasculitis: 10 years devoted to lessen toxicity 

Rossi GM, Peyronel F, Fenaroli P, Maritati F, Vaglio A.

Clin Exp Rheumatol 2020; 38 Suppl 124: 18-22

6.  Erdheim-Chester disease: a challenging diagnosis for an effective therapy 

Todisco A, Cavaliere C, Vaglio A, Marano M, Bonometti A, Passoni E, Berti E, Cirillo M, Cirillo G.

Clin Neurol Neurosurg 2020; 194:105841

7.  Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19) 

Bartiromo M, Borchi B, Botta A, Bagalà A, Lugli G, Tilli M, Cavallo A, Xhaferi B, Cutruzzulà R, Vaglio A, Bresci S, Larti A, Bartoloni A, Cirami C.

        Transplant Infect Dis 2020; 22(4): e13286

8.  Idiopathic retroperitoneal fibrosis: an update for nephrologists 

Raglianti V, Rossi GM, Vaglio A.

        Nephrol Dial Transplant 2020; 36(10): 1773-1781

9.  Erdheim-Chester disease: Consensus recommendations for the evaluation, diagnosis, and treatment in the  molecular era 

Goyal G, Heaney M, Collin M, Cohen-Aubart F, Vaglio A, Durham BH, Rokah O, Girschikofsky M, Jacobsen E, Toyama K, Goodman AM, Hendrie P, Cao X, Estrada-Veras JI, Shpilberg O, Abdo A, Kurokawa M, Dagna L, McClain KL, Mazor RD, Picarsic J, Janku F, Go RS, Haroche J, Diamond EL on Behalf of the Erdheim-Chester disease Global Alliance 

Blood 2020; 135:1929-1945 

1.  FCGR3B polymorphism predicts relapse risk in Eosinophilic Granulomatosis with Polyangiitis

Alberici F, Bonatti F, Adorni A, Daminelli G, Sinico RA, Gregorini G, Marvisi C, Fenaroli P, Peyronel F, Maritati F, Palmisano A, Urban ML, Percesepe A, Emmi G, Martorana D*, Vaglio A*.

        Rheumatology (Oxford) 2020; 59(11): 3563-3566

1.  Long-term follow-up of mTOR inhibition in Erdheim-Chester disease 

Pegoraro F, Maniscalco V, Peyronel F, Westenend PJ, Hendriksz TJ, Roperto RM, Palumbo AA, Sieni E, Romagnani P, van Bommel EFH, Vaglio A.

Blood 2020; 135:1994-1997 

2.  Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis 

Walsh M, Merkel PA, Peh CA, Szpirt WM, Puéchal X, Fujimoto S, Hawley CM, Khalidi N, Floßmann O, Wald R, Girard LP, Levin A, Gregorini G, Harper L, Clark WF, Pagnoux C, Specks U, Smyth L, Tesar V, Ito-Ihara T, de Zoysa JR, Szczeklik W, Flores-Suárez LF, Carette S, Guillevin L, Pusey CD, Casian AL, Brezina B, Mazzetti A, McAlear CA, Broadhurst E, Reidlinger D, Mehta S, Ives N, Jayne DRW; PEXIVAS Investigators. (Dr Vaglio included as collaborator)

N Engl J Med 2020; 382: 622-631 

3.  The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG₄-related disease .

Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group (Dr Vaglio included as collaborator)

Ann Rheum Dis 2020; 79: 77-87 

4.  The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG₄-related disease .

Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Kubota K, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Sekiguchi H, Schleinitz N, Stone JR, Takahashi N, Umehara H, Webster G, Zen Y, Stone JH; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. (Dr Vaglio included as collaborator)

Arthritis Rheumatol 2020; 72: 7-19 

5.  Manifestations of skull base IgG4-related disease: A multi-institutional study 

Marinelli JP, Marvisi C, Vaglio A, Peters PA, Dowling EM, Palumbo AA, Lane JI, Appelbaum EN, Sweeney AD, Carlson ML.

        Laryngoscope 2020; 130(11): 2574-2580

6.  IgG4-related disease: a clinical perspective 

Maritati F, Peyronel F, Vaglio A.

Rheumatology (Oxford) 2020; 59(Supplement_3):iii123-iii131 

7.  Stem-cell derived circulating progenitors dysfunction in Behçet’s syndrome patients correlates with oxidative stress 

Emmi G, Mannucci A, Argento F, Silvestri E, Vaglio A, Bettiol A, Fanelli A, Stefani L, Taddei N, Prisco D, Fiorillo C, Becatti M.

Front Immunol 2019; 10: 2877

8.  Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients 

Urban ML, Maritati F, Palmisano A, Fenaroli P, Peyronel F, Trivioli G, Ferretti S, De Biase C, Grayson PG, Pegoraro F, Prisco D, Romagnani P, Emmi G, Vaglio A.

Ann Rheum Dis 2020; 79: 433-434 

9.  Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management 

Trivioli G, Terrier B, Vaglio A.

Rheumatology (Oxford) 2020; 59(Supplement_3):iii84-iii94

1.  Reverse phenotyping after whole exome sequencing in steroid-resistant nephrotic syndrome 

Landini S, Mazzinghi B, Becherucci F, Allinovi M, Provenzano A, Palazzo V, Ravaglia F, Artuso R, Bosi E, Stagi S, Sansavini G, Guzzi F, Cirillo L, Vaglio A, Murer L, Peruzzi L, Pasini A, Materassi M, Roperto RM, Anders HJ, Rotondi M, Giglio SR, Romagnani P.

Clin J Am Soc Nephrol 2020; 15: 89-100 

1.  Randomized trial of two after-dialysis gabapentin regimens for severe uremic pruritus in hemodialysis patients 

Rossi GM, Corradini M, Blanco V, Mattei S, Fiaccadori E, Vaglio A, Manenti L.

Intern Emerg Med 2019; 14:1341-1346 

2.  New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group 

Marvisi C, Sinico RA, Salvarani C, Jayne D, Prisco D, Terrier B, Emmi G, Vaglio A; European EGPA Study Group.

Intern Emerg Med 2019; 14:1193-1197

3.  Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab. 

Bersanelli M, Gnetti L, Vaglio A, Sverzellati N, Campanini N, Incerti M, Galetti M, Varotti E, Corrado M, Parziale R, Bottarelli L, Azzoni C, Silini EM, Leonardi F, Buti S. 

Acta Biomed. 2019;90(4):468-474.

4.  Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 

Lyons PA, Peters JE, Alberici F, Liley J, Coulson RMR, Astle W, Baldini C, Bonatti F, Cid MC, Elding H, Emmi G, Epplen J, Guillevin L, Jayne DRW, Jiang T, Gunnarsson I, Lamprecht P, Leslie S, Little MA, Martorana D, Moosig F, Neumann T, Ohlsson S, Quickert S, Ramirez GA, Rewerska B, Schett G, Sinico RA, Szczeklik W, Tesar V, Vukcevic D, The European Vasculitis Genetics Consortium, Terrier B, Watts RA, Vaglio A, Holle JU, Wallace C, Smith KGC.

Nat Commun 2019; 10: 5120 

5.  Fibrocytes in chronic periaortitis. A novel link between inflammation and fibrosis 

Nicastro M, Vescovini R, Maritati F, Palmisano A, Urban ML, Incerti M, Fenaroli P, Peyronel F, Benigno GD, Mangieri D, Volpi R, Becchi G, Romagnani P, Corradi D, Vaglio A.

Arthritis Rheumatol 2019; 71(11):1913-1922  NON COINCIDE IL TITOLO

6.  Podocytes and Proteinuria in ANCA-Associated Glomerulonephritis: A Case-Control Study 

Van Daalen EE, Neeskens P, Zanbergen M, Harper L, Karras A, Vaglio A, de Zoysa J, Bruijn JA, Bajema IM.

Front Immunol 2019; 10: 1405

7.  Rituximab as maintenance treatment for systemic lupus erythematosus: a multicentre observational study of 147 patients 

Cassia MA, Alberici F, Jones RB, Smith RM, Casazza G, Urban ML, Emmi G, Moroni G, Sinico RA, Messa P, Hall F, Vaglio A, Gallieni M, Jayne DR

Arthritis Rheumatol 2019; 71:1670-1680 

8.  Neutrophil Extracellular Traps protein composition is specific for patients with lupus nephritis and includes methyl-oxidized αenolase (methionine sulfoxide 93) 

Bruschi M, Petretto A, Santucci L, Vaglio A, Pratesi F, Migliorini P, Bertelli R, Lavarello C, Bartolucci M, Candiano G, Prunotto M, Ghiggeri GM

Sci Rep 2019; 9: 7934 

9.  Clinical and prognostic significance of serum IgG4 in chronic periaortitis. An analysis of 113 patients

Maritati F, Rocco R, Accorsi Buttini E, Marvisi C, Nicastro M, Urban ML, Fenaroli P, Peyronel F, Benigno GD, Palumbo AA, Corradi D, Emmi G, Pipitone N, Palmisano A, Vaglio A.

Front Immunol 2019; 10: 693 

1.  Adult-onset IgA vasculitis (Henoch-Schönlein): update on therapy 

Maritati F, Canzian A, Fenaroli P, Vaglio A.

         Presse Med 2020; 49(3): 104035

1.  Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 

Bruschi M, Bonanni A, Petretto A, Vaglio A, Pratesi F, Santucci L, Migliorini P, Bertelli R, Galetti M, Belletti S, Cavagna L, Moroni G, Franceschini F, Fredi M, Pazzola G, Allegri L, Sinico R, Pesce G, Bagnasco M, Manfredi AA, Ramirez G, Ramoino P, Bianchini P, Puppo F, Pupo F, Negrini S, Mattana F, Emmi G, Garibotto G, Santoro D, Scolari F, Ravelli A, Tincani A, Cravedi P, Volpi S, Candiano G, Ghiggeri GM.

        J Rheumatol 2020; 47(3): 377-386

2.  Aortitis and periaortitis: the puzzling spectrum of inflammatory aortic diseases 

Marvisi C, Accorsi Buttini E, Vaglio A.

        Presse Med 2020; 49(1): 104018

3.  Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts 

Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH; ACR/EULAR IgG4-RD Classification Criteria Committee (Dr Vaglio included as collaborator).

Ann Rheum Dis 2019; 78: 406-412 

4.  Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis: a randomised, non-inferiority trial 

Jones RB, Hiemstra TF, Ballarin J, Blockmans DE, Brogan P, Bruchfeld A, Cid MC, Dahlsveen K, de Zoysa J, Espigol-Frigolé G, Lanyon P, Peh CA, Tesar V, Vaglio A, Walsh M, Walsh D, Walters G, Harper L, Jayne D; European Vasculitis Study Group (EUVAS).

Ann Rheum Dis 2019; 78: 399-405

5.  A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility 

González-Serna D, Carmona EG, Ortego-Centeno N, Simeón CP, Solans R, Hernández-Rodríguez J, Tolosa C, Castañeda S, Narváez J, Martinez-Valle F; European GCA Consortium; European Scleroderma Group, Witte T, Neumann T, Holle J, Beretta L, Boiardi L, Emmi G, Cimmino MA, Vaglio A, Herrick AL, Denton CP, Salvarani C, Cid MC, Morgan AW, Fonseca C, González-Gay MA, Martín J, Márquez A.

PLoS ONE 2018;13(12):e0209343

6.  Skull base manifestations of Erdheim-Chester disease: a case series and systematic review

Marinelli JP, Pierce PA, Vaglio A, Van Gompel JJ, Lane JI, Carlson ML. 

Neurosurgery 2019; 85: E693-E701

7.  Chronic periaortitis: an update 

Palmisano A, Maritati F, Vaglio A.

Curr Rheumatol Rep 2018; 20: 80 

8.  Low-Dose Tocilizumab For Relapsing Giant Cell Arteritis In The Elderly, Fragile Patient: Beyond The GiACTA Trial 

Rossi GM, Mannoni A, Di Scala G, Silvestri E, Cojan RD, Vannozzi L, Bettiol A, Vaglio A, Emmi G.

Autoimmun Rev 2018; 17: 1265-7 

9.  A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 

Martorana D, Márquez A, Carmona FD, Bonatti F, Adorni A, Urban ML, Maritati F, Accorsi Buttini E, Marvisi C, Palmisano A, Rossi GM, Trivioli G, Fenaroli P, Manenti L, Nicastro M, Incerti M, Gianfreda D, Bani S, Ferretti S, Corradi D, Alberici F, Emmi G, Di Scala G, Moroni G, Percesepe A, Scheel PJ, Vermeer E, van Bommel EF, Martín J, Vaglio A.

J Allergy Clin Immunol 2018; 142: 1662-5 

1.  Drug-induced lupus: traditional and new concepts 

Vaglio A, Grayson PC, Fenaroli P, Gianfreda D, Boccaletti V, Ghiggeri GM, Moroni G.

Autoimmun Rev 2018; 17: 912-8 

1.  Long-term disease control in Granulomatosis with Polyangiitis: is low-dose rituximab the cure? 

Trivioli G, Vaglio A.

Rheumatology 2019; 58: 380-381 

2.  Association of a polymorphism of the fcγ-receptor 2a (fcgr2a) gene with chronic periaortitis Alberici F, Bonatti F, Maritati F, Urban ML, Moroni G, Emmi G, Adorni A, Reina M, Vaglio A*, Martorana D*.

Clin Exp Rheumatol 2018; 37(2):222-226

3.  Highlights of the 2^nd EUVAS vasculitis course 

Emmi G, Salvarani C, Prisco D, Jayne DRW, Vaglio A.

Clin Exp Rheumatol 2018; 36 Suppl 111: 3-11 

4.  Annexin A1 and Autoimmunity: From Basic Science to Clinical Applications 

Bruschi M, Petretto A, Vaglio A, Santucci L, Candiano G, Ghiggeri GM.

Int J Mol Sci 2018; 19 pii E1348 

5.  Hemoptysis in Behçet's syndrome: from bedside to bench? 

Rossi GM, Emmi G, Vaglio A.

Intern Emerg Med 2018; 13: 467-9 

6.   Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 

Moroni G, Gilles Vercelloni P, Quaglini S, Gatto M, Gianfreda D, Sacchi L, Raffiotta F, Zen M, Costantini G, Urban ML, Pieruzzi F, Messa P, Vaglio A, Sinico RA, Doria A.

Ann Rheum Dis 2018; 77: 1318-25 

7.  Adalimumab-based treatment versus DMARDs for venous thrombosis in Behcet syndrome. A retrospective study of 70 patients with vascular involvement 

Emmi G, Vitale A, Silvestri E, Boddi M, Becatti M, Fiorillo C, Fabiani C, Frediani B, Emmi L, Di Scala G, Goldoni M, Bettiol A, Vaglio A*, Cantarini L*, Prisco D*.

Arthritis Rheumatol 2018; 70: 1500-7

8.  A misleading diagnosis of granulomatosis with polyangiitis (Wegener’s) disguising Whipple’s disease 

Peyronel F, Fenaroli P, Benigno GD, Palumbo AA, Martella E, Biagi F, Vaglio A.

Rheumatology (Oxford) 2018; 57: 1307-1309

9.  Malignant Mönckeberg medial calcific sclerosis 

Pisani I, De Troia A, Allegri L, Corradi D, Vaglio A.

Intern Emerg Med 2018; 13: 615-7 

1.  FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome 

Rossi GM, Bonatti F, Adorni A, Alberici F, Bodria M, Bonanni A, Ghiggeri GM, Martorana D, Vaglio A.

Immunol Lett 2018; 193: 11-13 

1.  Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein) 

Maritati F, Fenoglio R, Pillebout E, Emmi G, Urban ML, Rocco R, Nicastro M, Incerti M, Goldoni M, Trivioli G, Silvestri E, Mohammad AJ, Jayne D, Eriksson P, Segelmark M, Novikov P, Harris H, Roccatello D, Vaglio A.

Arthritis Rheumatol 2018: 70: 109-14

2. ¹⁸F-Fluorodeoxyglucose positron emission tomography and response to therapy in idiopathic retroperitoneal fibrosis.

Accorsi Buttini E, Maritati F, Vaglio A.

Eur Urol 2018; 73: 145-6 

3.  Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: a randomised trial 

Maritati F, Alberici F, Oliva E, Urban ML, Palmisano A, Santarsia F, Andrulli S, Pavone L, Pesci A, Grasselli C, Santi R, Tumiati B, Manenti L, Buzio C, Vaglio A.

Plos ONE 2017; 12: e0185880

4.  Scheduled rituximab maintenance reduces relapse rate in Eosinophilic Granulomatosis with Polyangiitis 

Emmi G, Rossi GM, Urban ML, Silvestri E, Prisco D, Goldoni M, Vaglio A.

Ann Rheum Dis 2018; 77: 952-4 

5.  Erdheim-Chester disease: the targeted revolution 

Vaglio A, Diamond EL.

Blood 2017; 130: 1282-4 

6.  Antineutrophil Cytoplasmic Antibody-Associated Vasculitides and IgG4-Related Disease: a new overlap syndrome 

Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, Maynard C, Luminita L, Garrouste C, Lioger B, Cottet R, Dhote R, Arlet JB, Hanslik T, Rouvier P, Ebbo M, Puéchal X, Nochy D, Carlotti A, Mouthon L, Guillevin L, Vaglio A, Terrier B, on behalf of the French Vasculitis Study Group

Autoimmun Rev 2017; 16: 1036-43 

7.   ANCA-associated vasculitis in childhood: recent advances 

Calatroni M, Oliva E, Gianfreda D, Gregorini G, Allinovi M, Ramirez GA, Bozzolo EP, Monti S, Bracaglia C, Marucci G, Bodria M, Sinico RA,Pieruzzi F, Moroni G, Pastore S, Emmi G, Esposito P, Catanoso M, Barbano G, Bonanni A, Vaglio A.

Ital J Pediatr 2017; 43: 46 

8.  Monogenic autoinflammatory diseases with Mendelian inheritance: genes, mutations and genotype/phenotype correlations 

Martorana D, Bonatti F, Mozzoni P, Vaglio A, Percesepe A.

Front Immunol 2017; 8: 344 

9.  Complement blockade in ANCA-associated vasculitis: an index case, current concepts and future perspectives 

Manenti L, Urban ML, Maritati F, Galetti M, Vaglio A.

Intern Emerg Med 2017; 12: 727-31 

1.   Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy 

Carmona FD, Coit P, Saruhan-Direskeneli G, Hernández-Rodríguez J, Cid MC , Solans R , Castañeda S, Vaglio A, Direskeneli H, Merkel PA, Boiardi L, Spanish GCA Study Group, Italian GCA Study Group, Turkish Takayasu Study Group, Vasculitis Clinical Research Consortium, Salvarani C, González-Gay MA, Martín J, Sawalha AH.

Sci Rep 2017; 7: 43953 

1.  Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease 

Rossi GM, Rocco R, Accorsi Buttini E, Marvisi C, Vaglio A.

Intern Emerg Med 2017; 12: 287-99 

2.  Immuno-inhibitory checkpoint deficiency in medium and large vessel vasculitis 

Zhang H, Watanabe R, Berry GJ, Vaglio A, Liao J, Warrington KJ, Goronzy JJ, Weyand C.

Proc Natl Acad Sci USA 2017; 114 E970-9 

3.  A genome-wide association study identifies
4.  risk alleles in plasminogen and P4HA2 associated with giant cell arteritis  

Carmona FD, Vaglio A, Mackie SL, Hernandez Rodriguez J, Monach PA, Castaneda S, Solans R, Morado IC, Narvaez J, Ramentol-Sintas M, Pease CT, Dashupta B, Watts R, Khalidi N, Langford CA, Ytterberg S, Boiardi L, Beretta L, Govoni M, Emmi G, Bonatti F, Cimmino MA, Witte T, Neumann T, Holle JU, Schonau V, Sailler L, Papo T, Haroche J, Mahr A, Mouthon L, Molberg O, Diamantopoulos AP, Voskuyl A, Brouwer E, Daikeler T, Berger CT, Molloy ES, O’Neill L, Blockmans D, Lie BA, McLaren P, Vyse TJ, Wijmenga C, Allanore Y, Koeleman BPC, Barrett JH, Cid MC, Salvarani C, Merkel PA, Morgan AW, Gonzalez-Gay MA, Martin J.

Am J Hum Genet 2017; 100: 64-74 

5.  Post-translational modified proteins are biomarkers of autoimmune-processes: NETosis and the inflammatory-autoimmunity connection 

Bruschi M, Petretto A, Bertelli R, Galetti M, Bonanni A, Pratesi F, Migliorini P, Candiano G, Vaglio A, Ghiggeri GM.

Clin Chim Acta 2017; 464: 12-16 

6. Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise.

Aydin SZ, Direskeneli H, Merkel PA; International Delphi on Disease Activity Assessment in Large-vessel Vasculitis. Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise. 

J Rheumatol. 2017;44(12):1928-1932 (Dr Vaglio included as collaborator)

7.  Editorial: Vascular inflammation in systemic autoimmunity 

Ramirez GA, Weyand CM, Vaglio A, Manfredi AA.

Front Immunol 2016; 7: 471 

8.  Histiocytoses: emerging neoplasia behind inflammation 

Haroche J, Rollins B, Cohen-Aubart F, Abdel-Wahab O, Emile JF, Donadieu J, Id Baih A, Vaglio A, Charlotte F, Amoura Z.

Lancet Oncol 2017; 18: e113-e125 

9.  Cardiovascular involvement in Erdheim-Chester disease: an MRI study 

Gianfreda D, Palumbo AA, Rossi E, Buttarelli L, Manari G, Martini C, De Filippo M, Vaglio A.

Blood 2016; 128: 2468-71 

1.  Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in ANCA-associated vasculitis . 

Alberici F, Smith RM, Fonseca M, Willcocks LC, Jones RB, Holle JU, Wieczorek S, Neumann T, Martorana D, Gregorini G, Sinico RA, Bruchfeld A, Gunnarson I, Ohlsson S, Baslund B, Tesar V, Hruskova Z, Cid MC, Vaglio A, Lyons PA, Smith KGC, Jayne RDW.

        J Allergy Clin Immunol 2017; 139: 1684-7 

1.  Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts 

Yates M, Watts R, Bajema I, Cid M, Crestani B, Hauser T, Hellmich B, Holle J, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel P, Mills J, Mooney J, Segelmark M, Tesar V, Westman KWA, Vaglio A, Yalçındağ N, Jayne DR, Mukhtyar C.

RMD Open. 2017;3(1):e000449. 

2.  Idiopathic mediastinal fibrosis: a systemic immune-mediated disorder. A case series and a review of the literature 

Rossi GM, Emmi G, Corradi D, Urban ML, Maritati F, Landini F, Galli P, Palmisano A, Vaglio A.

Clin Rev Allergy Immunol 2017; 52: 446-59

3.  EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis 

Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalcındağ N, Jayne DR, Mukhtyar C.

Ann Rheum Dis 2016; 75: 1583-94 

4.  Erdheim-Chester disease as a mimic of IgG4-related disease: a case report and a review of a single-centre cohort 

Gianfreda D, Musetti C, Nicastro M, Maritati F, Cobelli R, Corradi D, Vaglio A.

Medicine (Baltimore) 2016; 95 (21): e3625

5.  Kidney involvement in medium- and large-vessel vasculitis 

Maritati F, Iannuzzella F, Pavia MP, Pasquali S, Vaglio A.

J Nephrol 2016; 29: 495-505 

6.  Idiopathic retroperitoneal fibrosis 

Vaglio A, Maritati F.

J Am Soc Nephrol 2016; 27: 1880-9 

7.  Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Behcet’s disease 

Becatti M, Emmi G, Silvestri E, Bruschi G, Ciucciarelli L, Squatrito D, Vaglio A, Taddei N, Abbate R, Emmi L, Goldoni M, Fiorillo C, Prisco D. 

Circulation 2016; 133: 302-11 

8.  Immunoglobulin G4-related disease: some missing pieces in a still unsolved complex puzzle 

Corradi D, Nicastro M, Vaglio A.

Cardiovasc Pathol 2016; 25: 90-2 

9.  FCGR3B copy number variations in Eosinophilic Granulomatosis with Polyangiitis 

Martorana D, Bonatti F, Alberici F, Gioffredi A, Reina M, Urban ML, Maritati F, Adorni A, Radice A, Pizzolato S, Gregorini G, Jeannin G, Guida G, Boita M, Pesci A, Moroni G, Neri TM, Sinico RA, Vaglio A.

J Allergy Clin Immunol 2016;137:1597-9 

1.  Association of serum C3 concentration and histological signs of thrombotic microangiopathy with outcomes among patients with ANCA-associated vasculitis 

Manenti L, Vaglio A, Gnappi E, Maggiore U, Allegri L, Allinovi M, Urban ML, Delsante M, Galetti M, Nicastro M, Pilato FP, Buzio C.

Clin J Am Soc Nephrol 2015;10:2143-51 

1.  Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial 

Gianfreda D, Nicastro M, Galetti M, Alberici F, Corradi D, Becchi G, Baldari G, De Filippo M, Ferretti S, Moroni G, Foti R, Di Gangi M, Jeannin G, Saffroy R, Emile JF, Buzio C, Vaglio A.

Blood 2015; 126:1163-71 

2.  Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management 

Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K, Dunogué B, Gross W, Holle J, Humbert M, Jayne D, Jennette JC, Lazor R, Mahr A, Merkel PA, Mouthon L, Sinico RA, Specks U, Vaglio A, Wechsler ME, Cordier JF, Guillevin L.

Eur J Intern Med 2015; 26: 545-53 

3.  Fibrosis- A common pathway to organ injury and failure  [letter]

Urban ML, Manenti L, Vaglio A.

N Engl J Med 2015; 373: 95-6  

4.  Multi-antibody composition in lupus nephritis: isotype and antibody specificity make the difference 

Bonanni A, Vaglio A, Bruschi M, Sinico RA, Cavagna L, Moroni G, Franceschini F, Allegri L, Pratesi F, Migliorini P, Candiano G, Pesce G, Ravelli A, Martini A, Puppo F, Tincani A, Ghiggeri GM.

Autoimmun Rev 2015; 14: 692-702 

5.  First report of FIP1L1-PDGFRα positive Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome)  (letter reporting original data)

Emmi G, Silvestri E, Marconi R, Carrai V, Fanelli T, Zucchini P, Marasca R, Vannucchi AM, Emmi L, Prisco D, Vaglio A.

Rheumatology (Oxford) 2015; 54: 1751-3 

6.  A large scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility

Carmona FD, Mackie SL, Martin JE, Taylor JC, Vaglio A, Eyre S, Bossini-Castillo L, Castañeda S, Cid MC, Hernández-Rodríguez J, Prieto-González S, Solans R, Ramentol-Sintas M, González-Escribano MF, Ortiz-Fernández L, Morado IC, Narváez J, Miranda-Filloy JA; Spanish GCA Group, Beretta L, Lunardi C, Cimmino MA, Gianfreda D, Santilli D, Ramirez GA, Soriano A, Muratore F, Pazzola G, Addimanda O, Wijmenga C, Witte T, Schirmer JH, Moosig F, Schönau V, Franke A, Palm Ø, Molberg Ø, Diamantopoulos AP, Carette S, Cuthbertson D, Forbess LJ, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Monach PA, Pagnoux C, Seo P, Spiera R, Sreih AG, Warrington KJ, Ytterberg SR, Gregersen PK, Pease CT, Gough A, Green M, Hordon L, Jarrett S, Watts R, Levy S, Patel Y, Kamath S, Dasgupta B, Worthington J, Koeleman BP, de Bakker PI, Barrett JH, Salvarani C, Merkel PA, González-Gay MA, Morgan AW, Martín J.

Am J Hum Genet 2015; 96: 565-80 

7.  Thrombosis in vasculitis: from pathogenesis to treatment 

Emmi G, Silvestri E, Amedei A, Niccolai E, D’Elios MM, Della Bella C, Grassi A, Becatti M, Fiorillo C, Emmi L, Vaglio A, Prisco D.

Thrombosis J 2015; 13: 15 

8.  Multifocal phaeohyphomycosis caused by Exophiala xenobiotica in a kidney transplant recipient 

Palmisano A, Morio F, Le Pape P, Degli Antoni AM, Ricci R, Zucchi A, Vaglio A, Piotti G, Antoniotti R, Cremaschi E, Buzio C, Maggiore U.

Transpl Infect Dis 2015; 17: 297-302 

9.  Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large-vessel vasculitis? 

Palmisano A, Urban ML, Corradi D, Cobelli R, Alberici F, Maritati F, Versari A, Pipitone N, Salvarani C, Buzio C, Vaglio A. 

Rheumatology (Oxford) 2015; 54: 2004-9 

1.  The evolving paradigm of cancer risk related to cyclphosphamide therapy in granulomatosis with polyangiitis (Wegener’s) 

Calatroni M, Buzio C, Vaglio A.

Rheumatology (Oxford) 2015; 54: 1339-41

1.  Genetic aspects of ANCA-associated vasculitis 

Alberici F, Martorana D, Vaglio A.

Nephrol Dial Transplant 2015; 30(suppl 1): i37-i45 

2.  A candidate gene approach identifies IL33 as a novel genetic risk factor for GCA 

Márquez A, Solans R, Hernández-Rodríguez J, Cid MC, Castañeda S, Ramentol M, Rodriguez-Rodriguez L, Narváez J, Blanco R, Ortego-Centeno N, Spanish GCA Consortium, Molberg Ø, Diamantopoulos AP, Latus J, Moosig F, Witte T, Beretta L, Salvarani C, Lunardi C, Cimmino MA, Vaglio A, González-Gay MA, Martín J.

 Plos ONE 2014; 9: e113476

3.  Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach 

Urban ML, Palmisano A, Nicastro M, Corradi D, Buzio C, Vaglio A.

Rev Med Interne 2015; 36: 15-21 

4.  Association between idiopathic retroperitoneal fibrosis and autoimmune thyroiditis: a case-control study 

Ceresini G, Urban ML, Corradi D, Lauretani F, Marina M, Usberti E, Palmisano A, Buzio C, Vaglio A.

Autoimmun Rev 2015; 14: 16-22 

5.  Adjuvant low-dose interleukin-2 (IL2) plus interferon-α (IFNα) in operable renal cell cancer. A phase III multicenter randomized trial of the Italian Oncology Group for Clinical Research (GOIRC) 

Passalacqua R, Caminiti C, Buti S, Porta C, Camisa R, Braglia L, Prati A, Vaglio A, Labianca R, Rondini E, Sabbatini R, Nastasi G, Artioli F, Potenzoni M, Alberici F, Oliva E, Buzio C.

J Immunother 2014; 37: 440-7  

6.  The kidney donor profile index (KDPI) of marginal donors allocated by standardized pre-transplant donor biopsy assessment: distribution and association with graft outcomes 

Gandolfini I, Buzio C, Zanelli P, Palmisano A, Cremaschi E, Vaglio A, Piotti G, Melfa L, La Manna G, Feliciangeli G, Cappuccilli M, Scolari MP, Capelli I, Panicali L, Baraldi O, Stefoni S, Buscaroli A, Ridolfi L, D'Errico A, Cappelli G, Bonucchi D, Rubbiani E, Albertazzi A, Mehrotra A, Cravedi P, Maggiore U.

 Am J Transplant 2014; 14: 2515-25

7.  Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study 

Goldoni M, Bonini S, Urban ML, Palmisano A, De Palma G, Galletti E, Coggiola M, Buzio C, Mutti A, Vaglio A.

Ann Intern Med 2014; 161: 181-8

8.   Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease 

Diamond EL, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, Ferrarini M, Abdel-Wahab O, Heaney ML, Scheel PJ, Feeley NK, Ferrero E, McClain KL, Vaglio A, Dagna L, Colby T, Arnaud L, Haroche J. 

Blood 2014; 124: 483-92  

9.  Impact of post-transplant lymphoproliferative disorders on kidney graft survival. A pilot study 

De Biase C, Maggiore U, Palmisano A, Bignardi L, Buzio C, Vaglio A.

Transplantation 2014; 15: e21-e25

1.  Genetics of ANCA-associated vasculitides: HLA and beyond 

Alberici F, Martorana D, Bonatti F, Gioffredi A, Lyons PA, Vaglio A.

 Clin Exp Rheumatol 2014; 32 (3 Suppl 82): S90-7 

1.  Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): evolutions in classification, etiopathogenesis, assessment and management 

Mahr A, Moosig F, Neumann T, Szczeklik W, Taillé C, Vaglio A, Zwerina J.

Curr Opin Rheumatol 2014; 26: 16-23 

2.  Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: a 3-year, prospective study 

Libri I, Gnappi E, Zanelli P, Reina M, Giuliodori S, Vaglio A, Palmisano A, Buzio C, Riva G, Barozzi P, Luppi M, Cravedi P, Maggiore U. 

 Am J Transplant 2013; 13: 3215-22

3.  Polyreactive Antibodies Developing Amidst Humoral Rejection of Human Kidney Grafts Bind Apoptotic Cells and Activate Complement 

Porcheray F, Fraser JW, Gao B, McColl A, DeVito J, Dargon I, Helou Y, Wong W, Girouard TC, Saidman SL, Colvin RB, Palmisano A, Maggiore U, Vaglio A, Neal Smith R, Zorn E.

 Am J Transplant 2013; 13: 2590-600 

4.  Comparison of PR3-ANCA specific assay performance for the diagnosis of granulomatosis with polyangiitis (Wegener’s) 

Radice A, Bianchi L, Maggiore U, Vaglio A, Sinico RA.

Clin Chem Lab Med 2013; 25:1-9 

5.  IL6 as an inflammatory mediator and target of therapy in chronic periaortitis 

Vaglio A, Catanoso MG, Spaggiari L, Magnani L, Pipitone N, Macchioni P, Pulsatelli L, Nicastro M, Becchi G, Corradi D, Versari A, Boiardi L, Salvarani C.

Arthritis Rheum 2013;65: 2469-75

6.  Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis 

Alberici F, Palmisano A, Urban ML, Maritati F, Oliva E, Manenti L, Ferretti S, Cobelli R, Buzio C, Vaglio A.

Ann Rheum Dis 2013; 72: 1584-6

7.  Atypical hemolytic uremic syndrome with underlying glomerulopathies. A case series and a review of the literature 

Manenti L, Gnappi E, Vaglio A, Allegri L, Noris M, Bresin E, Pilato FP, Valoti E, Pasquali S, Buzio C.

Nephrol Dial Transplant 2013; 28: 2246-59

8.  Use of Rituximab in Children with Steroid- and Calcineurin-Inhibitor-Dependent Idiopathic Nephrotic Syndrome 

Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, Bodria M, Caridi G, Wei C, Belingheri M, Ghio L, Merscher-Gomez S, Edefonti A, Pasini A, Montini G, Murtas C, Wang X, Muruve D, Vaglio A, Martorana D, Pani A, Scolari F, Reiser J, Ghiggeri GM.

Kidney Int 2013; 84: 1025-33 

9.  TLR4 and VEGF polymorphisms in chronic periaortitis 

Atzeni F, Boiardi L, Vaglio A, Nicoli D, Farnetti E, Palmisano A, Pipitone N, Martorana D, Moroni G, Longhi S, Bonatti F, Buzio C, Salvarani C.

Plos ONE 2013; 8: e62330

1.  Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art 

Vaglio A, Buzio C, Zwerina J.

Allergy 2013; 68: 261-73

1.  Retroperitoneal fibrosis 

Pipitone N, Vaglio A, Salvarani C.

Best Pract Res Clin Rheumatol 2012; 26: 439-48 

2.  Eotaxin/CCL11 in idiopathic retroperitoneal fibrosis 

Mangieri D, Corradi D, Martorana D, Malerba G, Palmisano A, Libri I, Bartoli V, Carnevali ML, Goldoni M, Govoni P, Alinovi R, Buzio C, Vaglio A.

Nephrol Dial Transplant 2012; 27: 3875-84 

3.  New aspects of membrano-proliferative glomerulonephritis  [letter]

Manenti L, Vaglio A, Buzio C.

N Engl J Med 2012; 367: 86 

4.  Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome and a new complement factor H mutation: report of a case 

Gnappi E, Allinovi M, Vaglio A, Bresin E, Sorosina E, Pilato FP, Allegri L, Manenti L.

Pediatr Nephrol 2012; 27: 1995-9

5.  Genetically distinct subsets within ANCA-associated vasculitis 

Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DRW, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloucas P, Feighery C, Gross WL, Guillevin L, Gunnarson I, Harper L, Hruskova Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JF, Savage CO, Segelmark M, Stegeman CA, Tesar V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KGC.

N Engl J Med 2012; 367: 214-23  

6.  IgG4-related disease  [letter]

Vaglio A, Zwerina J.

N Engl J Med 2012; 366: 1646-7  

7.  Rituximab therapy for chronic periaortitis 

Maritati F, Corradi D, Versari A, Casali M, Urban ML, Buzio C, Vaglio A.

Ann Rheum Dis 2012; 71: 1262-4

8.  PTPN22 R620W polymorphism in the ANCA-associated vasculitides 

Martorana D, Maritati F, Malerba G, Bonatti F, Alberici F, Oliva E, Sebastio P, Manenti L, Brugnano R, Catanoso MG, Fraticelli P, Guida G, Gregorini G, Possenti S, Moroni G, Leoni A, Pavone L, Pesci A, Sinico RA, Di Toma L, D’Amico M, Tumiati B, D’Ippolito R, Buzio C, Neri TM, Vaglio A.

      Rheumatology (Oxford) 2012; 51: 805-12 

9.  IgG4 immune rsponse in Churg-Strauss syndrome 

Vaglio A, Strehl J, Manger B, Maritati F, Alberici F, Beyer C, Rech J, Sinico RA, Bonatti F, Battistelli L, Distler JHW, Schett G, Zwerina J.

Ann Rheum Dis 2012; 71: 390-3 

1.  Churg-Strauss syndrome: update on pathophysiology and treatment 

Vaglio A, Moosig F, Zwerina J.

Curr Opin Rheumatol 2012; 24: 24-30 

1.  Differential structural remodeling of the left atrial posterior wall in patients affected by mitral regurgitation with or without persistent atrial fibrillation. A morphological and molecular study .

Corradi D, Callegari S, Maestri R, Ferrara D, Mangieri D, Alinovi R, Mozzoni P, Pinelli S, Goldoni M, Privitera YA, Bartoli V, Macchi E, Vaglio A, Benussi S, Alfieri O.

J Cardiovasc Electrophysiol 2012: 23: 271-9   

2.  Subclinical interstitial lung abnormalities in stable renal allograft recipients in the era of modern immunosuppression 

Bertolini L, Vaglio A, Bignardi L, Buzio C, De Filippo M, Palmisano A, Mercati K, Zompatori M, Maggiore U.

Transplant Proc 2011; 43:2617-23

3.  Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: a randomised controlled trial 

Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R, Ferrozzi F, Corradi D, Salvarani C, Buzio C.

Lancet 2011; 378: 338-46 

4.  Role of ¹⁸F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis 

Pipitone N, Versari A, Vaglio A, Salvarani C.

Clin Exp Rheumatol 2011; 29 (1 Suppl 64): S72-8 

5.  Candida sake as the causative agent of spondylodiscitis in a hemodialysis patient 

Palmisano A, Benecchi M, De Filippo M, Maggiore U, Buzio C, Vaglio A.

Spine J 2011; 11: e12-6

6.  Eotaxin-3 in Churg-Strauss Syndrome: A clinical and immunogenetic study 

Zwerina J, Bach C, Martorana D, Jatzwauk M, Hegasy G, Moosig F, Bremer J, Wieczorek S, Moschen A, Tilg H, Neumann T, Spriewald B, Schett G, Vaglio A.

Rheumatology (Oxford) 2011; 50:1823-7 

7.  CC chemokine receptor 5 polymorphism in chronic periaortitis 

Boiardi L, Vaglio A, Nicoli D, Farnetti E, Palmisano A, Pipitone N, Maritati F, Casali B, Martorana D, Moroni G, Gallelli B, Buzio C, Salvarani C.

Rheumatology (Oxford) 2011; 50: 1025-32 

8.   A cross-sectional study of the Birmingham Vasculitis Activity Score in systemic vasculitis 

Suppiah R, Mukhtyar C, Flossmann O, Alberici F, Baslund B, Batra R, Brown D, Holle J, Hruskova Z, Jayne D, Judge A, Little MA, Palmisano A, Stegeman C, Tesar V, Vaglio A, Westman K, Luqmani R.

Rheumatology (Oxford) 2011; 50: 899-905 

9.  Chronic periaortitis: a large vessel vasculitis? 

Vaglio A, Pipitone N, Salvarani C.

Curr Opin Rheumatol 2011; 23: 1-6

1.   Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index (VDI) with the Combined Damage Assessment Index (CDA) 

Suppiah R, Flossmann O, Mukhtyar C, Alberici F, Baslund B, Brown D, Hasan N, Holle J, Hruskova Z, Jayne D, Judge A, Little MA, Merkel PA, Palmisano A, Seo P, Stegeman C, Tesar V, Vaglio A, Westman K, Luqmani RA.

Ann Rheum Dis 2011: 70: 80-5

1.  Increased fetuin-A levels following treatment with a vitamin D analogue  [letter]

Manenti L, Vaglio A, Pasquali S.

Kidney Int 2010; 78: 1187

2.  EBV-associated leukoencephalopathy with late onset of central nervous system lymphoma in a kidney transplant recipient 

Vaglio A, Manenti L, Mancini C, Chierici E, Cobelli R, Bacci F, Palmisano A, Buzio C, Bignardi L, Maggiore U.

Am J Transplant 2010; 10: 948-52 

3.  Increased viral load after intravenous immunoglobulin therapy for BK virus associated nephropathy. A case report 

Maggiore U, Medici MC, Vaglio A, Buzio C.

Transplant Infect Dis 2010; 12: 470-2 

4.  Management of hepatitis C virus-related mixed cryoglobulinemia 

Iannuzzella F, Vaglio A, Garini G.

Am J Med 2010, 123: 400-8

5.   Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms 

Palmisano A, Corradi D, Carnevali L, Alberici F, Silini EM, Allegri L, Buzio C, Vaglio A.

       Clin Nephrol 2010; 74: 485-90 

6.  Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer 

Passalacqua R, Buzio C, Buti S, Porta C, Labianca R, Pezzuolo D, Camisa R, Sabbatini R, Benecchi L, Messina C, Cengarle R, Vaglio A, Dalla Chiesa M, Tomasello G, Caminiti C.

Cancer Immunol Immunother 2010; 59: 553-61 

7.  Retroperitoneal fibrosis revisited 

Vaglio A.

Medicine (Baltimore) 2009; 88: 208-10

8.  Churg Strauss syndrome 

      Vaglio A, Casazza I, Grasselli C, Corradi D, Sinico RA, Buzio C.

      Kidney Int 2009; 76: 1006-11  

9.  Peri-renal collateral circles 

Palmisano A, Cobelli R, Buzio C, Vaglio A.

Urology 2009; 74: 292-3 

1.  Chronic periaortitis: a fibro-inflammatory disorder 

Palmisano A, Vaglio A.

       Best Pract Res Clin Rheumatol 2009; 23: 339-53 

1.   Uremic pruritus: clinical characteristics, pathophysiology and treatment 

Manenti L, Tansinda P, Vaglio A

Drugs 2009; 69: 251-63 

2.  Chronically administered immunotherapy with low-dose IL2 and IFNα in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profile .

Vaglio A*, Alberici F*, Maggiore U, Buti S, Potenzoni D, Passalacqua R, Buzio C.

Oncology 2009; 76: 69-76 

3.  Retroperitoneal fibrosis associated with psoriasis. A case series 

Famularo G, Palmisano A, Afeltra A, Buzzulini F, Versari A, Minisola G, Vaglio A.

Scand J Rheumatol 2009; 38: 68-9 

4.  Pericarditis heralding Erdheim-Chester disease

Vaglio A, Corradi D, Maestri R, Callegari S, Buzio C, Salvarani C.

Circulation 2008; 118: e511-e512 

5.  Images in cardiovascular medicine. Chronic periaortitis 

Pipitone N, Ghinoi A, Versari A, Vaglio A, Palmisano A, Salvarani C.

Circulation 2008; 118: 1214-6 

6.  Eprodisate in AA amyloidosis: a novel therapeutic approach? 

Manenti L, Tansinda P, Vaglio A.

Exp Opin Pharmacother 2008; 9: 2175-80

7.  TLR-mediated induction of negative regulatory ligands on dendritic cells 

Groeschel S*, Piggott K*, Vaglio A*, Ma-Krupa W, Singh K, Goronzy JJ, Weyand CM.

J Mol Med 2008; 86: 443-55 

8.  Gabapentin as a therapeutic option in uremic pruritus  [letter]

Manenti L, Vaglio A, Borgatti PP.

Kidney Int 2008; 73: 512 

9.  Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature 

Vaglio A, Palmisano A, Ferretti S, Alberici F, Casazza I, Salvarani C, Buzio C.

Rheumatology (Oxford) 2008; 47: 315-8 

1.  Eprosidate for AA amyloidosis 

Manenti L, Tansinda P, Vaglio A.

N Engl J Med 2007; 357: 1153-4 

1.  Retroperitoneal fibrosis: evolving concepts 

Vaglio A, Palmisano A, Corradi D, Salvarani C, Buzio C.

Rheum Dis Clin North Am 2007; 33: 803-17

2.  Idiopathic retroperitoneal fibrosis: clinico-pathologic features and differential diagnosis with other fibrosing diseases 

Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L, Ferretti S, Cobelli R, Moroni G, Dei Tos AP, Buzio C, and Vaglio A.

Kidney Int 2007; 72: 742-53

3.  HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome 

Vaglio A*, Martorana D*, Maggiore U, Grasselli C, Zanetti A, Pesci A, Garini G, Manganelli P, Bottero P, Tumiati B, Sinico RA, Savi M, Buzio C, Neri TM.

Arthritis Rheum 2007; 56: 3159-66  

4.  Meningeal involvement in apparently ANCA-negative Wegener granulomatosis. A role for PR3-capture ELISA? 

Greco P, Palmisano A, Vaglio A, Scoditti U, Antonelli MY, Crisi G, Sinico RA, Buzio C.

Rheumatology (Oxford) 2007; 46: 1375-6 

5.  Pure red cell aplasia followed by disseminated intravascular coagulation in a hemodialysis patient receiving epoietin-β 

Manenti L, Vaglio A. 

Nephrol Dial Transplant 2007, 22: 1465-7

6.  Gabapentin use in chronic uremic itch is in line with emerging pathogenetic hypothesis  [letter]

Manenti L, Vaglio A.   

Nephrol Dial Transplant 2007; 22: 3669-70  

7.  Calciphylaxis: evolving concepts 

Garini G, Galletti E, Ricci R, Vaglio A, Buzio C

Intern Emerg Med 2006; 1: 320-2 

8.  Autoimmune aspects of chronic periaortitis 

Vaglio A, Greco P, Corradi D, Palmisano A, Martorana D, Ronda N, Buzio C.

Autoimmun Rev 2006; 5: 458-64  

9.  Outcome and prognostic factors during the course of primary small-vessel vasculitides 

Pavone L, Grasselli C, Chierici E, Maggiore U, Garini G, Ronda N, Manganelli P, Pesci A, Rioda WT, Tumiati B, Pavesi G, Vaglio A, Buzio C.

J Rheumatol 2006; 33: 1299-306 

1.  Ear, nose and throat manifestations of Churg-Strauss syndrome 

Bacciu A, Bacciu S, Mercante G, Ingegnoli F, Grasselli C, Vaglio A, Pasanisi E, Vincenti V, Garini G, Ronda N, Ferri T, Corradi D, Buzio C. 

Acta Otolaryngol 2006; 126: 503-9 

1.  Tamoxifen for retroperitoneal fibrosis  [letter]

Vaglio A, Greco P, Buzio C.

Ann Intern Med 2006; 144: 619 

2.  Retroperitoneal fibrosis 

Vaglio A, Salvarani C, Buzio C. 

Lancet 2006; 367: 241-51 

3.  Chronic periaortitis and HLA DRB1*03. Another clue to an autoimmune origin 

Martorana D*, Vaglio A*, Greco P, Zanetti A, Moroni G, Salvarani C, Savi M, Buzio C, Neri TM. 

Arthritis Rheum 2006; 55: 126-30 

4.  Tuberculosis as a  trigger  of retroperitoneal fibrosis 

Greco P*, Vaglio A*, Corradi D, Cobelli R, Zompatori M, Buzio C.

Clin Infect Dis 2005; 41: e72-5 

5.  Gabapentin for uraemic pruritus  [letter]

Manenti L, Vaglio A. 

Nephrol Dial Transplant 2005; 20: 1278-9 

6.  Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent  scar ? A study using ¹⁸F-fluorodeoxyglucose positron emission tomography 

Vaglio A, Greco P, Versari A, Filice A, Cobelli R, Manenti L, Salvarani C, Buzio C.

Clin Exp Rheumatol 2005; 23: 231-4 

7.  Gabapentin in the treatment of uraemic itch: an index case and a pilot evaluation 

Manenti L, Vaglio A, Costantino E, Danisi D, Oliva B, Pini S, Prati E, Testori A.

J Nephrol 2005; 18:86-91 

8.  Positron emission tomography (PET) evaluation of chronic periaortitis  

Salvarani C, Pipitone N, Versari A, Vaglio A, Serafini D, Bajocchi GL, Salvo D, Buzio C, Greco P, Boiardi L.

Arthritis Rheum 2005; 53:298-303 

9.  18F-Fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of idiopathic retroperitoneal fibrosis 

Vaglio A, Versari A, Fraternali A, Ferrozzi F, Salvarani C, Buzio C.

Arthritis Rheum 2005; 53: 122-5 

1. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies. 

         Garini G, Allegri L, Vaglio A, Buzio C. 

         Ann Ital Med Int. 2005 Apr-Jun;20(2):71-80

1.  Chronic periaortitis: a spectrum of diseases 

Vaglio A, Buzio C.

Curr Opin Rheumatol 2005; 17: 34-40 

2.  Low doses of subcutaneous interleukin-2 plus interferon-α do not induce thyroid function alterations in advanced renal cell carcinoma patients .

Sartore-Bianchi A, Soriani A, Mattioni R, Vaglio A, Buzio C, Porta C. 

Oncol Rep 2004; 12: 855-9 

3.  Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death 

Corradi D, Vaglio A, Maestri R, Legname V, Leonardi G, Bartoloni G, Buzio C.

Hum Pathol 2004; 35; 1160-3 

4.  Large bowel obstruction heralding Churg-Strauss syndrome 

Vaglio A, Corradi D, Ronda N, Garini G, Buzio C.

Am J Gastroenterol  2004; 99: 562-3 

5.  Prognostic significance of albuminuria in patients with renal cell cancer 

Vaglio A, Buzio L, Cravedi P, Pavone L, Garini G, Buzio C.

J Urol 2003; 170: 1135-7

6.  Evidence of autoimmunity in chronic periaortitis: a prospective study 

Vaglio A, Corradi D, Manenti L, Ferretti S, Garini G, Buzio C.

Am J Med 2003; 114: 454-62 

7.  ANCA-positive periaortic vasculitis: does it fall within the spectrum of vasculitis? 

Vaglio A, Manenti L, Allegri L, Ferrozzi F, Corradi D, Buzio C.

J Intern Med 2002; 251: 268-71 

8.  Long-term immunotherapy with low-dose interleukin-2 and interferon-α in the treatment of patients with metastatic renal cell carcinoma 

Buzio C, Andrulli S, Santi R, Pavone L, Passalacqua R, Potenzoni D, Ferrozzi F, Giacosa R, Vaglio A.

Cancer 2001; 92: 2286-96 

*contributed equally

Last updated  06.12.2023

                                                                                                                     Augusto Vaglio